• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前体信使核糖核酸的5' 剪接差异:从致病基因变异中挽救功能性蛋白质特性及范可尼贫血D1型患者的生命线

Pre-mRNA Differential 5' Splicing: A Rescue of Functional Protein Properties from Pathogenic Gene Variants and a Lifeline for Fanconi Anemia D1 Patients.

作者信息

Paredes Roberto, Batta Kiran, Wiseman Daniel H, Gothbi Reham, Dalal Vineet, Schmidt Christine K, Kalb Reinhard, Meyer Stefan, Schindler Detlev

机构信息

Epigenetics of Haematopoiesis Laboratory, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK.

Manchester Cancer Research Centre (MCRC), Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK.

出版信息

Int J Mol Sci. 2025 Jul 12;26(14):6694. doi: 10.3390/ijms26146694.

DOI:10.3390/ijms26146694
PMID:40724944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12295132/
Abstract

Fanconi anemia (FA) is a DNA repair deficiency disorder associated with genomic and chromosomal instability and a high cancer risk. In a small percentage of cases, FA is caused by biallelic pathogenic variants (PVs) in the gene, defining the FA-D1 subtype. Experimental and epidemiologic data indicate that the complete absence of BRCA2 is incompatible with viability. Therefore, cells from individuals affected with FA caused by biallelic PVs must have a residual BRCA2 function. This activity may be maintained through hypomorphic missense mutations, translation termination-reinitiation associated with a translational stop mutation, or other non-canonical or uncommon translation initiation and elongation events. In some cases, however, residual BRCA2 function is provided by alternatively or aberrantly spliced transcripts. Here, we review and debate aspects of the contribution of splicing in the 5' segment to BRCA2 functions in the context of PVs affecting this largely intrinsically disordered protein region, with a focus on recent findings in individuals with FA-D1. In this Perspective, we also discuss some of the broader biological implications and open questions that arise from considering 5'-terminal splicing in light of old and new findings from FA-D1 patients and beyond.

摘要

范可尼贫血(FA)是一种与基因组和染色体不稳定以及高癌症风险相关的DNA修复缺陷疾病。在一小部分病例中,FA由该基因的双等位基因致病性变异(PVs)引起,定义为FA-D1亚型。实验和流行病学数据表明,完全缺乏BRCA2与生存能力不相容。因此,由双等位基因PVs导致FA的个体的细胞必须具有残余的BRCA2功能。这种活性可能通过亚效错义突变、与翻译终止突变相关的翻译终止-重新起始或其他非经典或不常见的翻译起始和延伸事件得以维持。然而,在某些情况下,残余的BRCA2功能由可变剪接或异常剪接的转录本提供。在此,我们回顾并讨论了在影响这一主要为内在无序蛋白区域的PVs背景下,5'端剪接对BRCA2功能贡献的相关方面,并重点关注了FA-D1个体的最新研究发现。在本观点中,我们还根据FA-D1患者及其他方面的新老研究结果,讨论了考虑5'端剪接所产生的一些更广泛的生物学意义和未解决的问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8932/12295132/69fd5f4d5a51/ijms-26-06694-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8932/12295132/286e3cae7216/ijms-26-06694-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8932/12295132/c4d39656e575/ijms-26-06694-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8932/12295132/69fd5f4d5a51/ijms-26-06694-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8932/12295132/286e3cae7216/ijms-26-06694-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8932/12295132/c4d39656e575/ijms-26-06694-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8932/12295132/69fd5f4d5a51/ijms-26-06694-g003.jpg

相似文献

1
Pre-mRNA Differential 5' Splicing: A Rescue of Functional Protein Properties from Pathogenic Gene Variants and a Lifeline for Fanconi Anemia D1 Patients.前体信使核糖核酸的5' 剪接差异:从致病基因变异中挽救功能性蛋白质特性及范可尼贫血D1型患者的生命线
Int J Mol Sci. 2025 Jul 12;26(14):6694. doi: 10.3390/ijms26146694.
2
Fanconi Anemia范可尼贫血
3
Analysis of , and related Fanconi anemia identifies scope to expand disease phenotypic features and predict breast cancer risk in heterozygotes.对与范可尼贫血相关的[具体基因名称缺失]、[具体基因名称缺失]和[具体基因名称缺失]的分析确定了扩大疾病表型特征范围以及预测杂合子患乳腺癌风险的可能性。
medRxiv. 2025 May 26:2025.05.25.25327887. doi: 10.1101/2025.05.25.25327887.
4
Short-Term Memory Impairment短期记忆障碍
5
Isolated Methylmalonic Acidemia孤立性甲基丙二酸血症
6
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.液体活检能否通过低深度全基因组测序检测肉瘤患者的循环肿瘤DNA?一项初步评估。
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
7
Beta-Thalassemiaβ地中海贫血
8
Gastric cancer risk and BRCA1/2 mutations: a systematic review and meta-analysis.胃癌风险与BRCA1/2突变:一项系统综述与荟萃分析
Per Med. 2025 Aug;22(4):245-256. doi: 10.1080/17410541.2025.2531737. Epub 2025 Jul 13.
9
Epidermolysis Bullosa Simplex单纯性大疱性表皮松解症
10
Metastatic malignant cylindroma arising on a background of digenic inheritance of BRCA2 and CYLD pathogenic variants targeted with PARP inhibition.在BRCA2和CYLD致病变异的双基因遗传背景下发生的转移性恶性圆柱瘤,采用PARP抑制靶向治疗。
Clin Exp Dermatol. 2025 Jun 25;50(7):1322-1329. doi: 10.1093/ced/llaf064.

本文引用的文献

1
Genetic inactivation of FAAP100 causes Fanconi anemia due to disruption of the monoubiquitin ligase core complex.FAAP100的基因失活由于单泛素连接酶核心复合物的破坏而导致范可尼贫血。
J Clin Invest. 2025 Apr 15;135(11). doi: 10.1172/JCI187323. eCollection 2025 Jun 2.
2
Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS and AML.剪接调节剂可损害 DNA 损伤反应并诱导黏连蛋白突变型 MDS 和 AML 细胞死亡。
Sci Transl Med. 2024 Jan 3;16(728):eade2774. doi: 10.1126/scitranslmed.ade2774.
3
The splicing factor SNRPB promotes ovarian cancer progression through regulating aberrant exon skipping of POLA1 and BRCA2.
剪接因子 SNRPB 通过调节 POLA1 和 BRCA2 的异常外显子跳跃促进卵巢癌进展。
Oncogene. 2023 Jul;42(31):2386-2401. doi: 10.1038/s41388-023-02763-x. Epub 2023 Jun 30.
4
Principles, mechanisms, and biological implications of translation termination-reinitiation.翻译终止-再起始的原理、机制和生物学意义。
RNA. 2023 Jul;29(7):865-884. doi: 10.1261/rna.079375.122. Epub 2023 Apr 6.
5
A novel cancer risk prediction score for the natural course of FA patients with biallelic BRCA2/FANCD1 mutations.一种用于预测携带 BRCA2/FANCD1 双等位基因突变的 FA 患者自然病程中癌症风险的新评分。
Hum Mol Genet. 2023 May 18;32(11):1836-1849. doi: 10.1093/hmg/ddad017.
6
Heterozygous BRCA1 and BRCA2 and Mismatch Repair Gene Pathogenic Variants in Children and Adolescents With Cancer.杂合性 BRCA1 和 BRCA2 及错配修复基因致病性变异与儿童和青少年癌症。
J Natl Cancer Inst. 2022 Nov 14;114(11):1523-1532. doi: 10.1093/jnci/djac151.
7
Loss of the BRCA1-PALB2 interaction accelerates p53-associated tumor development in mice.BRCA1与PALB2相互作用的丧失会加速小鼠中与p53相关的肿瘤发展。
Genes Dis. 2020 Sep 5;9(3):807-813. doi: 10.1016/j.gendis.2020.08.012. eCollection 2022 May.
8
Comparative multi-tissue profiling reveals extensive tissue-specificity in transcriptome reprogramming during thermal adaptation.比较多组织分析揭示了在热适应过程中转录组重编程的广泛组织特异性。
Elife. 2022 May 17;11:e78556. doi: 10.7554/eLife.78556.
9
EMSY inhibits homologous recombination repair and the interferon response, promoting lung cancer immune evasion.EMSY 抑制同源重组修复和干扰素反应,促进肺癌的免疫逃逸。
Cell. 2022 Jan 6;185(1):169-183.e19. doi: 10.1016/j.cell.2021.12.005. Epub 2021 Dec 27.
10
Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2).因 FANCD1(BRCA2)或 FANCN(PALB2)致病性变异导致的范可尼贫血患者的基因型-癌症相关性。
Cancer Genet. 2021 Nov;258-259:101-109. doi: 10.1016/j.cancergen.2021.10.001. Epub 2021 Oct 4.